Disease mutations in desmoplakin inhibit Cx43 membrane targeting mediated by desmoplakin–EB1 interactions

DM Patel, AD Dubash, G Kreitzer, KJ Green - Journal of Cell Biology, 2014 - rupress.org
DM Patel, AD Dubash, G Kreitzer, KJ Green
Journal of Cell Biology, 2014rupress.org
Mechanisms by which microtubule plus ends interact with regions of cell–cell contact during
tissue development and morphogenesis are not fully understood. We characterize a
previously unreported interaction between the microtubule binding protein end-binding 1
(EB1) and the desmosomal protein desmoplakin (DP), and demonstrate that DP–EB1
interactions enable DP to modify microtubule organization and dynamics near sites of cell–
cell contact. EB1 interacts with a region of the DP N terminus containing a hotspot for …
Mechanisms by which microtubule plus ends interact with regions of cell–cell contact during tissue development and morphogenesis are not fully understood. We characterize a previously unreported interaction between the microtubule binding protein end-binding 1 (EB1) and the desmosomal protein desmoplakin (DP), and demonstrate that DP–EB1 interactions enable DP to modify microtubule organization and dynamics near sites of cell–cell contact. EB1 interacts with a region of the DP N terminus containing a hotspot for pathogenic mutations associated with arrhythmogenic cardiomyopathy (AC). We show that a subset of AC mutations, in addition to a mutation associated with skin fragility/woolly hair syndrome, impair gap junction localization and function by misregulating DP–EB1 interactions and altering microtubule dynamics. This work identifies a novel function for a desmosomal protein in regulating microtubules that affect membrane targeting of gap junction components, and elucidates a mechanism by which DP mutations may contribute to the development of cardiac and cutaneous diseases.
rupress.org